Zacks Research Brokers Increase Earnings Estimates for FMS

Fresenius Medical Care AG (NYSE:FMS - Free Report) - Research analysts at Zacks Research lifted their Q3 2025 earnings estimates for shares of Fresenius Medical Care in a research report issued on Tuesday, May 27th. Zacks Research analyst I. Bandyopadhyay now anticipates that the company will post earnings of $0.56 per share for the quarter, up from their previous estimate of $0.54. The consensus estimate for Fresenius Medical Care's current full-year earnings is $1.51 per share. Zacks Research also issued estimates for Fresenius Medical Care's Q4 2025 earnings at $0.66 EPS, FY2025 earnings at $2.12 EPS, Q2 2026 earnings at $0.51 EPS, Q3 2026 earnings at $0.62 EPS, Q4 2026 earnings at $0.68 EPS, FY2026 earnings at $2.29 EPS, Q1 2027 earnings at $0.51 EPS and FY2027 earnings at $2.32 EPS.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.01. The company had revenue of $5.54 billion for the quarter, compared to analysts' expectations of $4.71 billion. Fresenius Medical Care had a return on equity of 6.04% and a net margin of 3.43%.

Other analysts have also issued reports about the stock. Truist Financial upped their price target on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Wall Street Zen started coverage on Fresenius Medical Care in a report on Tuesday, May 20th. They issued a "strong-buy" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. One research analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $27.80.

Fresenius Medical Care Stock Performance

NYSE FMS traded up $0.35 on Thursday, hitting $28.75. The stock had a trading volume of 305,839 shares, compared to its average volume of 331,853. The stock has a market cap of $16.87 billion, a price-to-earnings ratio of 23.77, a P/E/G ratio of 0.76 and a beta of 0.85. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. Fresenius Medical Care has a one year low of $17.93 and a one year high of $30.46. The company's 50-day moving average is $25.96 and its two-hundred day moving average is $24.31.

Hedge Funds Weigh In On Fresenius Medical Care

Institutional investors have recently bought and sold shares of the stock. Pzena Investment Management LLC grew its position in shares of Fresenius Medical Care by 0.6% in the first quarter. Pzena Investment Management LLC now owns 15,377,090 shares of the company's stock valued at $382,890,000 after purchasing an additional 94,065 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Fresenius Medical Care by 50.0% during the 1st quarter. Millennium Management LLC now owns 1,083,602 shares of the company's stock worth $26,982,000 after acquiring an additional 361,364 shares during the period. Integral Health Asset Management LLC boosted its position in shares of Fresenius Medical Care by 33.3% during the 4th quarter. Integral Health Asset Management LLC now owns 600,000 shares of the company's stock valued at $13,584,000 after acquiring an additional 150,000 shares in the last quarter. Todd Asset Management LLC bought a new stake in Fresenius Medical Care in the first quarter valued at about $12,009,000. Finally, Northern Trust Corp raised its position in Fresenius Medical Care by 5.0% in the first quarter. Northern Trust Corp now owns 380,251 shares of the company's stock worth $9,468,000 after purchasing an additional 18,061 shares in the last quarter. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care Increases Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Friday, May 23rd will be paid a $0.7871 dividend. This represents a dividend yield of 1.9%. The ex-dividend date of this dividend is Friday, May 23rd. This is a positive change from Fresenius Medical Care's previous annual dividend of $0.44. Fresenius Medical Care's payout ratio is presently 49.11%.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.